The Natural Product Oridonin as an Anticancer Agent: Current Achievements and Problems

被引:3
作者
Hu, Xiangyan [1 ]
Huang, Sisi [1 ,2 ]
Ye, Shiying [1 ]
Jiang, Jinhuan [1 ,3 ]
机构
[1] Univ South China, Hengyang Med Sch, Inst Pharm & Pharmacol, Sch Pharmaceut Sci, Hengyang 421001, Hunan, Peoples R China
[2] Fudan Univ, Pharm Sch, Shanghai Inst Biomed & Pharmaceut Technol, NHC Key Lab Reprod Regulat, Shanghai 200032, Peoples R China
[3] Univ South China, Hengyang Med Sch, Hunan Prov Key Lab Tumor Microenvironm Respons Dru, Hengyang 421001, Hunan, Peoples R China
基金
湖南省自然科学基金;
关键词
Oridonin; anticancer; molecular mechanism; signaling pathway; herbal medicine; apoptosis; EPITHELIAL-MESENCHYMAL TRANSITION; CELL-CYCLE ARREST; INHIBITS MIGRATION; MELANOMA-CELLS; CANCER GROWTH; APOPTOSIS; AUTOPHAGY; PATHWAY; CARCINOMA; INVASION;
D O I
10.2174/1389201024666230821110116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oridonin, an active diterpenoid isolated from traditional Chinese herbal medicine, has received a rising attention for its remarkable roles in cancer therapy. In recent years, increasing evidences have revealed that oridonin inhibits the occurrence and development of tumor cells through multiple mechanisms, including induction of apoptosis and autophagy, cell cycle arrest, and inhibition of angiogenesis as well as migration and invasion. In addition, several molecular signal targets have been identified, including ROS, EGFR, NF-kappa B, PI3K/Akt, and MAPK. In this paper, we review considerable knowledge about the molecular mechanisms and signal targets of oridonin, which has been studied in recent years. It is expected that oridonin may be developed as a novel anti-tumor herbal medicine in human cancer treatment.
引用
收藏
页码:655 / 664
页数:10
相关论文
共 88 条
  • [1] An Insight into the Anti-Angiogenic and Anti-Metastatic Effects of Oridonin: Current Knowledge and Future Potential
    Abdullah, Nurul Akmaryanti
    Md Hashim, Nur Fariesha
    Ammar, Aula
    Muhamad Zakuan, Noraina
    [J]. MOLECULES, 2021, 26 (04):
  • [2] MEDICINE FROM PLANTS
    ABELSON, PH
    [J]. SCIENCE, 1990, 247 (4942) : 513 - 513
  • [3] Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway
    Bao, Runfa
    Shu, Yijun
    Wu, Xiangsong
    Weng, Hao
    Ding, Qian
    Cao, Yang
    Li, Maolan
    Mu, Jiasheng
    Wu, Wenguang
    Ding, Qichen
    Tan, Zhujun
    Liu, Tianyu
    Jiang, Lin
    Hu, Yunping
    Gu, Jianfeng
    Liu, Yingbin
    [J]. BMC CANCER, 2014, 14
  • [4] Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells
    Bohanon, Fredrick J.
    Wang, Xiaofu
    Graham, Brittany M.
    Prasai, Anesh
    Vasudevan, Sadhashiva J.
    Ding, Chunyong
    Ding, Ye
    Radhakrishnan, Geetha L.
    Rastellini, Cristiana
    Zhou, Jia
    Radhakrishnan, Ravi S.
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 410 (1-2) : 293 - 300
  • [5] Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53-and caspase- dependent induction of p38 MAPK
    Bu, He-Qi
    Liu, Dian-Lei
    Wei, Wei-Tian
    Chen, Liang
    Huang, Hai
    Li, Ye
    Cui, Jun-Hui
    [J]. ONCOLOGY REPORTS, 2014, 31 (02) : 975 - 982
  • [6] AMPK/mTOR/ULK1 Axis-Mediated Pathway Participates in Apoptosis and Autophagy Induction by Oridonin in Colon Cancer DLD-1 Cells
    Bu, Heqi
    Liu, Dianlei
    Zhang, Guolin
    Chen, Li
    Song, Zhangfa
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 8533 - 8545
  • [7] ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells
    Cai, Duo-te
    Jin, Hua
    Xiong, Qi-Xing
    Liu, Wei-Guang
    Gao, Zhi-gang
    Gu, Gui-xiong
    Qiu, Yu-hui
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 379 (1-2) : 161 - 169
  • [8] Molecular mechanisms of apoptosis and autophagy elicited by combined treatment with oridonin and cetuximab in laryngeal squamous cell carcinoma
    Cao, Shijie
    Huang, Yiyuan
    Zhang, Qiang
    Lu, Fangjin
    Donkor, Paul Owusu
    Zhu, Yan
    Qiu, Feng
    Kang, Ning
    [J]. APOPTOSIS, 2019, 24 (1-2) : 33 - 45
  • [9] Oridonin stabilizes retinoic acid receptor alpha through ROS-activated NF- κB signaling
    Cao, Yang
    Wei, Wei
    Zhang, Nan
    Yu, Qing
    Xu, Wen-Bin
    Yu, Wen-Jun
    Chen, Guo-Qiang
    Wu, Ying-Li
    Yan, Hua
    [J]. BMC CANCER, 2015, 15
  • [10] Targeting autophagy to overcome drug resistance: further developments
    Chang, Haocai
    Zou, Zhengzhi
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)